References
- Ahmad F, Rossen L, Spencer M, Warner M, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. 2018. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm?wpisrc=nl_health202&wpmm=1. Accessed August 9, 2018.
- Sordo L, Barrio G, Bravo MJ. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550
- Oliva EM, Trafton JA, Harris AH, Gordon AJ. Trends in opioid agonist therapy in the Veterans Health Administration: is supply keeping up with demand? Am J Drug Alcohol Abuse. 2013;39(2):103–107.
- Wyse JJ, Gordon AJ, Dobscha SK, et al. Medications for opioid use disorder in the Department of Veterans Affairs (VA) Health Care System: historical perspective, lessons learned and next steps. Subst Abus. 2018 Mar 29. [Epub ahead of print]. doi: 10.1080/08897077.2018.1452327
- Oliva EM, Maisel NC, Gordon AJ, Harris AH. Barriers to use of pharmacotherapy for addiction disorders and how to overcome them. Curr Psychiatry Rep. 2011;13:374–381.
- Courtwright DT. Preventing and treating narcotic addiction-century of federal drug control. N Engl J Med. 2015;373:2095–2097.
- Jin Fuey Moy v. United States, 254 U.S. 189 (1920). https://www.law.cornell.edu/supremecourt/text/254/189. Accessed October 22, 2018.
- Narcotic Addict Treatment Act of 1974. Public Law No. 93–281. https://www.gpo.gov/fdsys/pkg/STATUTE-88/pdf/STATUTE-88-Pg124.pdf. Accessed August 9, 2018.
- Drug Addiction Treatment Act of 2000. Public Law No. 106–310, Title XXXV. https://www.congress.gov/106/plaws/publ310/PLAW-106publ310.pdf. Accessed August 9, 2018.
- Comprehensive Addiction and Recovery Act of 2016. Public Law No. 114–198. https://www.congress.gov/114/plaws/publ198/PLAW-114publ198.pdf. Accessed August 9, 2018.
- Tierney M, Finnell DS, Naegle MA, LaBelle C, Gordon AJ. Advanced practice nurses: Increasing access to opioid treatment by expanding the pool of qualified buprenorphine prescribers. Subst Abus. 2015;36:389–392.
- Physician and Program Data. https://www.samhsa.gov/programs-campaigns/medication-assisted-treatment/training-materials-resources/physician-program-data. Accessed October 22, 2018.
- Wu LT, Zhu H, Swartz MS. Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend. 2016;169:117–127.
- Valenstein-Mah H, Hagedorn H, Kay CL, Christopher ML, Gordon AJ. Underutilization of the current clinical capacity to provide buprenorphine treatment for opioid use disorders within the Veterans Health Administration. Subst Abus. 2018 Oct 16 [Epub ahead of print]. doi: 10.1080/08897077.2018.1509251.
- Stein BD, Sorbero M, Dick AW, et al. Physician capacity to treat opioid use disorder with Buprenorphine-Assisted treatment. JAMA 2016;316:1211–1212.
- Jones CM, Campopiano M, Baldwin G, McCance-Katz E. National and state treatment need and capacity for opioid agonist Medication-Assisted treatment. Am J Public Health. 2015;105:e55–e63.
- Gordon AJ, Liberto J, Granda S, et al. Outcomes of DATA 2000 certification trainings for the provision of buprenorphine treatment in the Veterans Health Administration. Am J Addict. 2008;17:459–462.
- Gordon AJ, Liberto J, Granda S, et al. Physician training is never a failure. Am J Addict. 2009;18:337–338.
- Wakeman SE, Barnett ML. Primary care and the Opioid-Overdose Crisis-Buprenorphine myths and realities. N Engl J Med. 2018;379:1–4.
- Fatseas M, Dubernet J, Daoulouede J-P, Auriacombe M. Buprenorphine in the Treatment of Opioid Addiction: The French Experience. In: el-Guebaly N, Carra N, Galanter M, eds. Textbook of Addiction Treatment: International Perspectives. Vol 1. New York, NY: Springer; 2015.
- Schuman-Olivier Z, Albanese M, Nelson SE, et al. Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers. J Subst Abuse Treat. 2010;39:41–50.